Default Category
-
Laree Verbindungen GmbH
Ariño, Miguel Angel; Heukamp, FranzCase AD-361-EDecision AnalysisLaree is a German company that manufactures and supplies the fasteners that are used in construction to attach glass to the walls of buildings. Its executives must decide whether to accept a contract that could be a great opportunity to open a new market for the company or result in a significant loss of money. This case is based on the "Berfest AG" case by the same authors. This case replaces The Berfest case from the same authors (AD-314).Starting at €8.20
-
ERBITUX: A Miracle Drug Or Just a Lot of Headaches
Heukamp, Franz; Ariño, Miguel AngelCase AD-347-EDecision AnalysisIn February of 2002, Bernhard Scheuble, the CEO of Merck, received news that the U.S. Food and Drug Administration had "refused to file" Erbitux, a new "miracle" cancer treatment drug. The drug was supposed to have represented Merck's entry into the field of oncology. Erbitux had been an enormous gamble for the first non-family CEO in Merck's 350-year history. It had refocused the company's operations on an entirely new field: oncology. Adding to...Starting at €8.20
-
Vossloh: Restoring Trust after Two Consecutive Profit Warnings
Jan Diebecker; Alexander Flügel; Thorsten Knauer; Tea Luhtanen; Friedrich SommerCase IVEY-9B12M113-EStrategyVossloh AG is preparing for its annual December conference with investors and analysts. The company, whose core business has always been the railway engineering sector, had to issue two consecutive profit warnings in 2011, which sent its stock back to levels last seen only in the aftermath of the economic crisis of 2009–10. The company’s primary task is to find the right arguments to satisfy the conference participants and regain their trust. Vos...Starting at €8.20